Ginger and osteoporosis: protecting bones, stimulating osteoblasts, and inhibiting osteoclasts

Osteoporosis: a silent epidemic in Belgium

Osteoporosis affects 30% of Belgian women and 10% of men over 50. Hip fracture (severe consequence) has a 1-year mortality of 20–30%. Bone remodeling is a permanent balance: osteoblasts (formation) vs osteoclasts (resorption). With aging and a decrease in sex hormones → imbalance favoring resorption → progressive bone loss. Risk profiles: postmenopausal women, men >65 years, corticosteroid users, people with low calcium/D3, smokers.

Mechanisms of ginger on bone

1. Stimulation of osteoblasts (Wnt/β-catenin)

The Wnt/β-catenin pathway is the primary signal for differentiation and activation of osteoblasts. Phenolic compounds in ginger activate this pathway in osteoprogenitor cells → differentiation into mature osteoblasts → production of type I collagen, osteocalcin, ALP → bone mineralization. In vitro study: 6-gingerol increases osteoblastic differentiation by 40% vs control.

2. Inhibition of osteoclasts (RANKL/OPG)

RANKL (produced by osteoblasts and T-lymphocytes) binds to its receptor RANK on osteoclast precursors → differentiation into active osteoclasts → resorption. OPG (osteoprotegerin) is the natural decoy for RANKL. Ginger → inhibits RANKL (via inflammation-mecanisme-cle-ginger-sucre-explication-2026">NF-κB inhibition) and stimulates OPG → RANKL/OPG ratio favorable for formation → less bone resorption.

3. Protection of bone collagen

The bone matrix consists of 90% type I collagen. MMP-1 and MMP-13 (metalloproteases) degrade this collagen. Ginger inhibits these MMPs → preserves the organic matrix → less brittle bone, better maintained trabecular structure.

4. Reduction of peri-osseous inflammation (NF-κB)

Chronic inflammation (IL-1β, TNF-α, IL-6) is a major activator of osteoclasts. NF-κB in bone immune cells → increased RANKL → osteolysis. NF-κB inhibition by ginger → fewer pro-resorptive cytokines → better preserved bone.